201 related articles for article (PubMed ID: 2385834)
1. Down-regulation of muscarinic receptors in the striatum of organophosphate-treated swine.
Yang CM; Dwyer TM; Mohan PM; Ho IK; Farley JM
Toxicol Appl Pharmacol; 1990 Jul; 104(3):375-85. PubMed ID: 2385834
[TBL] [Abstract][Full Text] [Related]
2. Changes in affinity states during down-regulation of muscarinic receptors in tracheal smooth muscle of organophosphate-treated swine.
Yang CM; Mohan PM; Dwyer TM; Farley JM
J Auton Pharmacol; 1988 Jun; 8(2):79-91. PubMed ID: 3170629
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characteristics of muscarinic cholinoreceptors in swine tracheal smooth muscle.
Yang CM; Farley JM; Dwyer TM
J Auton Pharmacol; 1986 Mar; 6(1):15-24. PubMed ID: 3957950
[TBL] [Abstract][Full Text] [Related]
4. The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates.
Galper JB; Dziekan LC; O'Hara DS; Smith TW
J Biol Chem; 1982 Sep; 257(17):10344-56. PubMed ID: 7107608
[TBL] [Abstract][Full Text] [Related]
5. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
[TBL] [Abstract][Full Text] [Related]
6. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
[TBL] [Abstract][Full Text] [Related]
7. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
8. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
Das S; Matwyshyn GA; Bhargava HN
Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
[TBL] [Abstract][Full Text] [Related]
9. Muscarinic stimulation of submucosal glands in swine trachea.
Yang CM; Farley JM; Dwyer TM
J Appl Physiol (1985); 1988 Jan; 64(1):200-9. PubMed ID: 3356638
[TBL] [Abstract][Full Text] [Related]
10. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
11. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
[TBL] [Abstract][Full Text] [Related]
12. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropine.
Yamada S; Isogai M; Okudaira H; Hayashi E
Brain Res; 1983 Jun; 268(2):315-20. PubMed ID: 6871685
[TBL] [Abstract][Full Text] [Related]
13. [Effects of diisopropylfluorophosphate, paraoxon and dichlophos on [3H] quinuclidinyl benzylate binding to the rat striatum synaptic membranes].
Golovko AI; Sofronov GA; Nikolaeva TV; Kliuntina TV
Biull Eksp Biol Med; 1992 Sep; 114(9):290-1. PubMed ID: 1477363
[TBL] [Abstract][Full Text] [Related]
14. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
Watson M; Yamamura HI; Roeske WR
Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
[TBL] [Abstract][Full Text] [Related]
16. Contractile responses of tracheal smooth muscle in organophosphate-treated swine: 1. Agonist changes.
Murali Mohan P; Huang Saunders HM; Yang CM; Dwyer TM; Farley JM
J Auton Pharmacol; 1988 Jun; 8(2):93-106. PubMed ID: 2902099
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphoinositide turnover by selective muscarinic antagonists in the rat striatum. Correlation with receptor occupancy.
Monsma FJ; Abood LG; Hoss W
Biochem Pharmacol; 1988 Jun; 37(12):2437-43. PubMed ID: 2839194
[TBL] [Abstract][Full Text] [Related]
18. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
19. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
20. Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.
Adem A; Sabbagh M; Nordberg A
J Neural Transm; 1988; 72(1):11-8. PubMed ID: 3379385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
